This ties in very nicely with the mouse model work that was done a few years back at Harvard or Oxford (I can't remember off hand) that suggested Apabetalone (RVX-208) could potentially be a treatment for heart failure. I really wish RVX IR was more on top of this type of information and start connecting third party validation dots like this for potential investors.